PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F111. A total of 6 filers reported holding PASITHEA THERAPEUTICS CORP in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Warberg Asset Management LLC | 289,868 | $3,594 | 0.00% |
| Kepos Capital LP | 334,600 | $4 | 0.00% |
| Citadel Advisors | 13,204 | $162 | 0.00% |
| ARMISTICE CAPITAL, LLC | 50,000 | $615 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 34 | $0 | 0.00% |
This page lists PASITHEA THERAPEUTICS CORP's shareholders in Q1 2024. To view PASITHEA THERAPEUTICS CORP's shareholder history, click here.